About this event

  • Date and time Mon 25 Nov 2019 from 8:00am to 6:00pm
  • Location Royal Society of Medicine
  • Organised by Oncology

Join us for the 4th year of this important meeting, where a multidisciplinary faculty of prominent speakers from around the globe will discuss the importance of effective cancer control in low and middle-income countries (LMIC) and highlight the magnitude of the disparities and issues that currently exist. 

First-hand accounts of healthcare professionals working in these settings will share experiences to increase awareness on global cancer collaborations that currently exist, improve understanding of the challenges to delivering cancer care, and provide a forum to discuss future strategies to improve global cancer control. 

Topics include:

- Build collaborative networks between LMIC, UK and globally
- Address the global disparity in cancer care through collaborative networks
- Promote learning and sharing through practice and data-sharing across the globe
- Advocate for improvement in global cancer control and learn how to become further involved in this field
- Create a global grassroots network for cancer control in LMIC
- Provide an opportunity for attendees to showcase their work in this field

Key international healthcare organisations including THET and Kings Health Partners will be represented. 

Call for abstracts: Vanessa Moss annual prize

Prize: Winner of best abstract - £250 and invited for oral presentation; Top 10 abstracts – poster presentation

Submission deadline: 30 June 2019

Eligibility Criteria:

1. Any scientist or healthcare professional working in the field of global cancer control may apply

2. Collaborative research / service delivery in which the applicant has been significantly involved, in global cancer control, focusing on LMICs (as defined by world bank group)

3. The project may be clinical or scientific

4. Work may have been published previously (but not before 2018)

Abstract guidelines:

400 words maximum, including background, methods, results and discussion.

Submissions open to HICs and LMICs. The judging panel will include oncologists and experts in the field of global cancer care who will consider the originality and the impact of the research on the quality of care for patients with cancer in LMICs, within the context of the resources available to the host institution.

The winner must agree to attend the conference.

For further information and to submit, please contact oncology@rsm.ac.uk

Tickets

Early Bird pricing available until 15 September 2019.

Member

RSM Fellow RSM Associate RSM Retired Fellow RSM Trainee RSM Student
£55.00 £45.00 £45.00 £45.00 £25.00

Non - Member

Consultant / GP AHP / Nurse / Midwife Trainee Student
£92.00 £75.00 £75.00 £42.00

Key speakers

Dr Ophira Ginsburg

Dr Ophira Ginsburg

Director Perlmutter Cancer Center High Risk Program, New York University, New York, US

Speaker's biography

Dr Ophira Ginsburg, a Canadian national, is a medical oncologist with expertise in cancer epidemiology, prevention and screening, and a primary focus in women’s health equity and global cancer control. She is a fellow of the Royal College of Physicians and Surgeons (Canada) and a Scientist at Women’s College Hospital and Research Institute. She has been an advisor to the National Institute for Cancer Control of Vietnam, a member of the Technical Advisory Committee of the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, and a member of the Union for International Cancer Control’s Global Task Force on Radiotherapy for Cancer Control. Over the past 12 years she has developed an innovative programme of population intervention research, education, and policy initiatives in cancer disparities and global cancer control, with projects in Bangladesh, Canada, United Republic of Tanzania, United States and Viet Nam.

Dr Ginsburg joined the WHO Department for Management of Noncommunicable Diseases, Disability, Violence and Injury Prevention (NVI) in October 2015 as a Medical Officer for cancer control. Her focus is on building policy and programming for women’s cancers, including guidance, recommendations, and implementation frameworks on breast cancer prevention, early detection/screening and management in collaboration with the WHO International Agency for Research on Cancer (IARC) and other international experts and partners building upon existing WHO and IARC breast cancer related documents.

Dr Gilberto Lopes

Dr Gilberto Lopes

Medical Director for International Programs and Associate Director for Global Oncology, Sylvester Comprehensive Cancer Center; Associate Professor, University of Miami Miller School of Medicine

Speaker's biography

Dr. Gilberto Lopes, an expert in medical oncology in low- and middle-income countries, is Medical Director for International Programs and Associate Director for Global Oncology at the Sylvester Comprehensive Cancer Center and Associate Professor at the University of Miami Miller School of Medicine. He is an associate editor for ASCO University and for ASCO’s Journal of Global Oncology. From 2006 to 2013, Dr. Lopes worked for the Johns Hopkins University Singapore International Medical Center, and, prior to that, was the Chief Medical and Scientific Officer for the Oncoclinicas Group, the largest oncology provider in Latin America with 35 clinics and more than 300 oncologists in nine states in Brazil.

Dr. Lopes has published widely, with more than 100 papers in journals such as the Journal of Clinical Oncology, Cancer, The Lancet, The Lancet Oncology, and Nature Reviews, and has lectured nationally and internationally. He has been principal or co-principal investigator or steering committee member in more than 100 studies and clinical trials covering breast, gastrointestinal, genitourinary, and thoracic cancers. His areas of research interest extend to health economics, value, policy, and access to cancer drugs and treatment in low- and middle-income countries. He has served as an expert for the International Atomic Energy Agency, the World Health Organization and the Pan-American Health Organization.

After graduating from medical school in Brazil, Dr. Lopes received residency training in internal medicine and completed a fellowship in hematology/oncology at the University of Miami.

Professor Richard Sullivan

Professor Richard Sullivan

King's Health Partners, UK;
Director, Institute of Cancer Policy, Co-Director Conflict & Health Research Group, King's College London

Speaker's biography

Professor Richard Sullivan's research group studies health systems, particular NCD policy and the impact of conflict on health. He is Professor of Cancer and Global Health at King’s College London, and Director of the Institute of Cancer Policy (ICP) and co-Director of the Conflict and Health Research Group.  As well as holding a number of Visiting Chairs, Richard is an NCD advisor to the WHO, civil-military advisor to Save the Children, and a member of the National Cancer Grid of India His research focuses on global cancer policy and planning, and health systems strengthening, particularly conflict ecosystems. He is principle investigator on research programs ranging from automated radiotherapy planning for low resource settings to use of augmented/virtual reality for cancer surgery, through to political economy to build affordable, equitable cancer control plans. Richard has led five Lancet Oncology Commissions and worked on four others. He is currently co-leading Lancet Oncology commissions on the Future of Cancer Research in Europe and Cancer Care in Conflict. In conflict systems, his research teams have major programs in capacity building in conflict medicine across the Middle East and North Africa (r4hc-mena.org), as well as studies of the basic package of health services in Afghanistan, civil-military co-operation in health security, polio eradication and insecurity in Pakistan, and use of intelligence in high security disease outbreaks.  Professor Sullivan qualified in medicine and trained in surgery (urology), gaining his PhD from University College London. He was also clinical director of Cancer Research UK between 1999 and 2008. Following a period at the London School of Economics working on complex healthcare systems he moved to King’s College London in 2011. 

Agenda

View the programme

Registration, tea and coffee
Welcome and introduction

Dr Susannah Stanway, Consultant Medical Oncologist, Royal Marsden NHS Foundation Trust

SESSION ONE

Chair: David Collingridge

Title to be confirmed

Richard Sullivan, King's Health Partners, UK

The challenge of falsified medicines

Chloe Tuck and Oksana Pyzik, Commonwealth Pharmacy Association

Digital health in LMICs

Shafi Ahmed, St Bartholomew's Hospital, London, UK

Why an understanding of anthropology is so important for cancer control

Carlo Caduff, King's Health Partners

Tea and coffee break and poster viewing

THE VANESSA MOSS PRIZE

Vanessa Moss prize winner’s presentation

Presentation by winner

Creating a national advocacy movement

Beatrice Wiafe Addai, Peace and Love Hospital, Accra, Ghana

Understanding breast cancer survivorship in Tanzania

Nazima Dharsee, Ocean Road Cancer Institute, Dar es Salaam, Tanzania

Oncology collaborations within the THET project portfolio

Ben Simms, Chief Executive of THET, London

Lunch and poster viewing

WORKSHOPS

Africa

Nazima Dharsee, Beatrice Wiafe Addai and Groesbeck Parham

Asia

C.S. Pramesh, Tata Memorial Hospital, Mumbai, India, Bhawna Sirohi, Barts Health NHS Trust, Shailesh Bishal, Tata Memorial Hospital, Mumbai, India, Anil D’Cruz, Tata Memorial Hospital, Mumbai, India

Zambia

Groesbeck Parham

Ghana

Beatrice Wiafe Adai

SESSION TWO

Chair: Ophira Ginsburg

Resource stratified oncology guidelines

Ben Anderson, University of Washington, USA

Setting up a global oncology programme

Gilberto Lopes, Sylvester Cancer Center, Miami, USA

Title to be confirmed

Ophira Ginsburg, New York University, New York, USA

Tea and coffee break and poster viewing
India/Asia

C.S. Pramesh

Challenges and opportunities in developing a Cancer Center in an LMIC

Shailesh Shrikhande

The importance of engaging with decision makers

Di Sarfati, New Zealand

Closing remarks

Shailesh Bishal

Close of meeting
Optional

Meet the professors

Drinks reception

Location

Royal Society of Medicine, 1 Wimpole Street, London, W1G 0AE, United Kingdom